Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Acton Pharmaceuticals
company
About
Acton Pharmaceuticals is a specialty pharmaceutical company that develops and markets products for the treatment of respiratory conditions.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Close
Acton Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on acquiring, developing and commercializing products primarily for the treatment of respiratory conditions.The Company was founded by pharmaceutical executives experienced in respiratory product development and commercialization.Acton is actively pursing the acquisition of products in either late-stage clinical development or which are currently being marketed.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15M
Acton Pharmaceuticals has raised a total of
$15M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2010 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2010 | Series A | $15M | 1 |
Sequoia Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Acton Pharmaceuticals is funded by 1 investors.
Sequoia Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
